| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Zelira Therapeutics Limited (OTCQB: ZLDAF)
ZLDAF Technical Analysis
5
| As on 12th Nov 2024 ZLDAF STOCK Price closed @ 0.47 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.73 & Strong Sell for SHORT-TERM with Stoploss of 1.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ZLDAFSTOCK Price
| Open | 0.47 | Change | Price | % |
| High | 0.47 | 1 Day | 0.00 | 0.00 |
| Low | 0.47 | 1 Week | 0.05 | 11.90 |
| Close | 0.47 | 1 Month | -0.02 | -4.08 |
| Volume | N/A | 1 Year | -0.08 | -14.55 |
| 52 Week High 1.31 | 52 Week Low 0.19 | ||||
OTCQB USA Most Active Stocks
| SURG | 1.80 | 23.29% |
| FNMAS | 10.12 | 2.33% |
| FMCKJ | 9.73 | 0.83% |
| BMIX | 0.01 | % |
| FNMA | 3.16 | 4.98% |
| FMCC | 3.08 | 5.48% |
| BTCWF | 0.10 | 150.00% |
| EFSH | 0.36 | -7.69% |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| ZLDAF Daily Charts |
ZLDAF Intraday Charts |
Whats New @ Bazaartrend |
ZLDAF Free Analysis |
|
|
ZLDAF Important Levels Intraday
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
| RESISTANCE | 0.47 |
ZLDAF Forecast November 2024
| 4th UP Forecast | 1.11 |
| 3rd UP Forecast | 0.9 |
| 2nd UP Forecast | 0.78 |
| 1st UP Forecast | 0.65 |
| 1st DOWN Forecast | 0.29 |
| 2nd DOWN Forecast | 0.16 |
| 3rd DOWN Forecast | 0.04 |
| 4th DOWN Forecast | -0.17 |
ZLDAF Weekly Forecast
| 4th UP Forecast | 1.36 |
| 3rd UP Forecast | 1.07 |
| 2nd UP Forecast | 0.90 |
| 1st UP Forecast | 0.72 |
| 1st DOWN Forecast | 0.22 |
| 2nd DOWN Forecast | 0.04 |
| 3rd DOWN Forecast | -0.13 |
| 4th DOWN Forecast | -0.42 |
ZLDAF Forecast2024
| 4th UP Forecast | 2.63 |
| 3rd UP Forecast | 1.94 |
| 2nd UP Forecast | 1.51 |
| 1st UP Forecast | 1.08 |
| 1st DOWN Forecast | -0.14 |
| 2nd DOWN Forecast | -0.57 |
| 3rd DOWN Forecast | -1 |
| 4th DOWN Forecast | -1.69 |
Zelira Therapeutics Limited ( OTCQB USA Symbol : ZLDAF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ZLDAF Business Profile
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the development of cannabinoid-based medicines for the treatment of various medical conditions in Australia. The company is also involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid formulations to treat diabetes-associated cognitive decline. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. Zelira Therapeutics has strategic partnerships with Curtin University; the Telethon Kids Institute; the University of Western Australia; St. Vincent's Hospital; the Children's Hospital of Philadelphia (CHOP) on opioid reduction study; HAPA Pharm BV; and Ethicann. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was founded in 2003 and is headquartered in Perth, Australia. Address: 101 St Georges Terrace, Perth, WA, Australia, 6000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service